Magnetar Financial’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,283
| Closed | -$1.1M | – | 620 |
|
|
2024
Q3 | $1.1M | Buy |
+3,283
| New | +$1.1M | 0.02% | 277 |
|
|
2024
Q1 | – | Sell |
-4,336
| Closed | -$1.4M | – | 376 |
|
|
2023
Q4 | $1.4M | Buy |
4,336
+2,163
| +100% | +$698K | 0.04% | 229 |
|
|
2023
Q3 | $779K | Sell |
2,173
-734
| -25% | -$263K | 0.02% | 275 |
|
|
2023
Q2 | $1.1M | Buy |
+2,907
| New | +$1.1M | 0.02% | 263 |
|
|
2022
Q1 | – | Sell |
-1,220
| Closed | -$922K | – | 1326 |
|
|
2021
Q4 | $922K | Buy |
+1,220
| New | +$922K | 0.01% | 825 |
|
|
2021
Q2 | – | Sell |
-2,549
| Closed | -$1.46M | – | 1210 |
|
|
2021
Q1 | $1.46M | Buy |
+2,549
| New | +$1.46M | 0.01% | 621 |
|
|
2020
Q4 | – | Sell |
-414
| Closed | -$213K | – | 727 |
|
|
2020
Q3 | $213K | Sell |
414
-1,640
| -80% | -$844K | ﹤0.01% | 596 |
|
|
2020
Q2 | $927K | Buy |
+2,054
| New | +$927K | 0.03% | 195 |
|
|
2019
Q2 | – | Sell |
-737
| Closed | -$225K | – | 447 |
|
|
2019
Q1 | $225K | Sell |
737
-3,726
| -83% | -$1.14M | 0.01% | 362 |
|
|
2018
Q4 | $1.04M | Buy |
+4,463
| New | +$1.04M | 0.03% | 117 |
|
|
2018
Q1 | – | Sell |
-2,231
| Closed | -$532K | – | 576 |
|
|
2017
Q4 | $532K | Sell |
2,231
-3,568
| -62% | -$851K | 0.01% | 377 |
|
|
2017
Q3 | $1.29M | Buy |
5,799
+1,676
| +41% | +$373K | 0.02% | 224 |
|
|
2017
Q2 | $933K | Buy |
4,123
+1,941
| +89% | +$439K | 0.01% | 368 |
|
|
2017
Q1 | $435K | Buy |
+2,182
| New | +$435K | 0.01% | 487 |
|
|
2016
Q3 | – | Sell |
-2,752
| Closed | -$394K | – | 526 |
|
|
2016
Q2 | $394K | Buy |
2,752
+961
| +54% | +$138K | 0.01% | 244 |
|
|
2016
Q1 | $245K | Buy |
+1,791
| New | +$245K | ﹤0.01% | 296 |
|
|
2013
Q4 | – | Sell |
-4,842
| Closed | -$569K | – | 114 |
|
|
2013
Q3 | $569K | Buy |
+4,842
| New | +$569K | 0.01% | 245 |
|